Angiotensin‐converting enzyme 2 modulation of pyroptosis pathway in traumatic brain injury: A potential therapeutic target

Angiotensin‐converting enzyme 2 modulation of pyroptosis pathway in traumatic brain injury: A potential therapeutic target

Saved in:

Bibliographic Details
Main Authors:	Jinxiu Guo, Shiyuan Zhao, Xue Chu, Changshui Wang, Junjun Meng, Shanshan Wei, Jianhua Wang, Yujin Guo, Weihua Kong, Wenxue Sun, Tao Zhang, Ruili Dang, Mengqi Yang, Jing Chen, Pei Jiang
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	Clinical and Translational Medicine
Online Access:	https://doi.org/10.1002/ctm2.70167
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
by: Myla E. Moretti, et al.
Published: (2012-01-01)

Angiotensin-Converting Enzyme Inhibition and Parathyroid Hormone Secretion
by: Sarah Zaheer, et al.
Published: (2017-01-01)

The use of angiotensin-converting enzyme inhibitors in general medicine
by: M.L.I. Mashitisho
Published: (2012-08-01)

Enhancement of angiotensin converting enzyme (ACE) inhibitory activity of walnut peptides: Insights into the effect of ultrasound on protein structure and peptide function
by: Xueying Song, et al.
Published: (2025-03-01)

Delayed angioedema during therapy with angiotensin-converting enzyme inhibitors
by: Janković Slobodan M., et al.
Published: (2011-01-01)

An angiotensin-converting enzyme inhibitor in the combination treatment of rheumatoid arthritis
by: E. B. Komarova, et al.
Published: (2017-09-01)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
by: D. A. Napalkov, et al.
Published: (2016-01-01)

Neutrophil hypersegmentation in children receiving angiotensin converting enzyme inhibitors
by: Vedat Okutan, et al.
Published: (2008-10-01)

Icatibant in the Treatment of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema
by: Neil H. Crooks, et al.
Published: (2014-01-01)

Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease
by: Yudi Her Oktaviono, et al.
Published: (2020-04-01)

Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease
by: Yudi Her Oktaviono, et al.
Published: (2020-04-01)

Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
by: Hye-Ran Jun, et al.
Published: (2021-01-01)

Debatable points of using angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in patients with COVID-19
by: O. M. Drapkina, et al.
Published: (2020-07-01)

Is there a difference between an angiotensin-converting enzyme inhibitor and an angiotensin-specific receptor blocker for the treatment of hypertension?
by: James A. Ker
Published: (2015-05-01)

Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
by: Marco Rossato, et al.
Published: (2020-07-01)

THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION
by: D. B. Nebieridze, et al.
Published: (2015-12-01)

EXPERT CONSENSUS DOCUMENT ON ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CARDIOVASCULAR DISEASE
by: Jose Lopez-Sendon, et al.
Published: (2015-12-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

Hubungan Nilai Treshold dengan KadarAngiotensin Converting Enzyme-2
by: Sabar Hutabarat, et al.
Published: (2023-04-01)

Comparison of angiotensin converting enzyme 1 levels to the grading of knee osteoarthritis
by: Fidelia Elvira Da Costa Rao, et al.
Published: (2024-06-01)

Choosing the Right Angiotensin Converting Enzyme Inhibitors; Gender –Specific Approach
by: Neena Elsa Varghese, et al.
Published: (2024-12-01)

Molecular insights into the inhibition of angiotensin-converting enzyme 1 by hemopressin peptides
by: Priya Antony, et al.
Published: (2024-11-01)

New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition.
by: Miklós Fagyas, et al.
Published: (2014-01-01)

Angiotensin I converting enzyme (ACE) inhibitory activity and antihypertensive effects of rice peptides
by: Jingjing Dong, et al.
Published: (2022-11-01)

AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND CALCIUM ANTAGONIST COMBINATION IN PHARMACOTHERAPY OF ARTERIAL HYPERTENSION
by: L. L. Kirichenko, et al.
Published: (2014-02-01)

IMPACT OF ANGIOTENSIN-CONVERTING ENZYME GENE POLYMORPHISM ON THE DEVELOPMENT OF INSULIN RESISTANCE SYNDROME
by: G. E. Roitberg, et al.
Published: (2014-07-01)

A ROLE OF ANGIOTENSIN-CONVERTING ENZYME IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE SUMMARY
by: N. D. Elshin, et al.
Published: (2017-09-01)

OFF-TARGET EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: ADDITIONAL THERAPEUTIC BENEFITS
by: O. Yu. Shaidyuk, et al.
Published: (2013-12-01)

Synthetic Peptides as Structural Maquettes of Angiotensin-I Converting Enzyme Catalytic Sites
by: Zinovia Spyranti, et al.
Published: (2010-01-01)

Postanesthetic Severe Oral Angioedema in Patient’s Taking Angiotensin-Converting Enzyme Inhibitor
by: Acílio Marques, et al.
Published: (2014-01-01)

Angiotensin converting enzyme inhibitor-induced penile angioedema: A case report
by: Anthony Acosta, et al.
Published: (2025-03-01)

Expression of circulating angiotensin‐converting enzyme 2 in children with asthma and the effects of inhaled corticosteroids
by: Xiang Ma, et al.
Published: (2023-07-01)

The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension.
by: Mingfei Li, et al.
Published: (2021-01-01)

Variation of Concentrations of Angiotensin II, AngiotensinConverting Enzyme and Matrix Metalloprotease-9 in Tears and Serum of Patients with Diabetic Retinopathy
by: V. V. Neroev, et al.
Published: (2020-12-01)

A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE
by: G. Savarese, et al.
Published: (2015-09-01)

Effect of insertion/deletion polymorphism of angiotensin-converting enzyme gene on efficacy of antihypertensive therapy with angiotensin II receptor blockers
by: E. V. Rebrova, et al.
Published: (2024-01-01)

Selection of Angiotensin I Converting Enzyme Inhibitory Peptides from Enzymatic Hydrolysate of Pinctada martensii Using Surface Plasmon Resonance
by: XIA Xiaoyu, WEN Caixing, CAO Wenhong, QIN Xiaoming, LI Yujin, LIN Haisheng, CHEN Zhongqin, ZHENG Huina, ZHU Guoping, GAO Jialong
Published: (2025-04-01)

Angiotensin-converting enzyme gene: application possibilities in medicine and sports cardiology (literature review)
by: S. M. Malakhova
Published: (2018-02-01)

The effects of angiotensin-converting enzyme inhibitors in heart recipients: a single center experience
by: А. О. Shevchenko, et al.
Published: (2019-01-01)

I/D POLYMORPHISM OF ANGIOTENSINE CONVERTING ENZYME IN CHD PATIENTS OF DIFFERENT AGE AND GENDER
by: T. Yu. Rebrova, et al.
Published: (2014-10-01)